Vitamin D in Thyroid Disorders

Experimental and Clinical Endocrinology and Diabetes

Volumn 123, Issue 7, 2015, Pages 386-393

  Kmiec P ^a   Sworczak, K ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

autoimmune thyroiditis; calcitriol; Graves' disease; Hashimoto thyroiditis; hyperthyroidism; hypothyroidism; thyroid cancer; Vitamin D; Vitamin D deficiency

Indexed keywords

ANTINEOPLASTIC AGENT; CALCITONIN; CALCITRIOL; COLECALCIFEROL 24 HYDROXYLASE; THIAMAZOLE; THYROGLOBULIN; THYROTROPIN; THYROXINE; VITAMIN D; VITAMIN D RECEPTOR;

ANAPLASTIC THYROID CANCER; ARTICLE; AUTOIMMUNE THYROIDITIS; DNA POLYMORPHISM; GENE FREQUENCY; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; PAPILLARY THYROID CARCINOMA CELL; POSTPARTUM THYROIDITIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; THYROID CANCER; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROID FUNCTION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; PHYSIOLOGY; THYROID TUMOR;

HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; THYROID NEOPLASMS; THYROIDITIS, AUTOIMMUNE; VITAMIN D;

EID: 84945951498     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0035-1554714     Document Type: Article

References (81)

1. Abd El Gawad S. S., Abdul Samee E. R., Metwali A. A. et al. Vitamin D receptor gene polymorphism and its association with 1,25-dihydroxyvitamin D(3) in patients with Graves disease in an Egyptian population: a pilot study. Endocr Pract: 2012; 18.2 132 139
2. Autier P., Boniol M., Pizot C. et al. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol: 2014; 2.1 76 89
3. Balla B., Tobias B., Kosa J. P. et al. Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer. J Endocrinol Invest. 2014
4. Ban Y., Taniyama M., Ban Y. Vitamin D receptor gene polymorphisms in Hashimoto's thyroiditis. Thyroid: 2001; 11.6 607 608
5. Bikle D. D. Vitamin D and cancer: the promise not yet fulfilled. Endocrine: 2014; 46.1 29 38
6. Bizhanova A., Kopp P. Controversies concerning the role of pendrin as an apical iodide transporter in thyroid follicular cells. Cellular Physiology And Biochemistry: International Journal Of Experimental Cellular Physiology, Biochemistry, And Pharmacology: 2011; 28.3 485 490
7. Bizzaro G., Shoenfeld Y. Vitamin D and thyroid autoimmune diseases: the known and the obscure. Immunol Res: 2015; 61.1-2 107 109
8. Bouillon R. Vitamin D and extraskeletal health. UpToDate October 29, 2014 2014. Web. December 4: 2014
9. Bouillon R., Muls E., De Moor P. Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab: 1980; 51.4 793 797
10. Bozkurt N. C., Karbek B., Ucan B. et al. The association between severity of vitamin D deficiency and Hashimoto's thyroiditis. Endocr Pract: 2013; 19.3 479 484
11. Camurdan O. M., Doger E., Bideci A. et al. Vitamin D status in children with Hashimoto thyroiditis. J Pediatr Endocrinol Metab: 2012; 25.5-6 467 470
12. Chailurkit L. O., Aekplakorn W., Ongphiphadhanakul B. High vitamin D status in younger individuals is associated with low circulating thyrotropin. Thyroid: 2013; 23.1 25 30
13. Chailurkit L. O., Aekplakorn W., Ongphiphadhanakul B. High vitamin D status in younger individuals is associated with low circulating thyrotropin. Thyroid: Official Journal Of The American Thyroid Association: 2013; 23.1 25 30
14. Chen W., Lin H., Wang M. Immune intervention effects on the induction of experimental autoimmune thyroiditis. J Huazhong Univ Sci Technolog Med Sci: 2002; 22.4 343 345 354
15. Choi Y. M., Kim W. G., Kim T. Y. et al. Low levels of serum vitamin D3 are associated with autoimmune thyroid disease in pre-menopausal women. Thyroid: 2014; 24.4 655 661
16. Clinckspoor I., Hauben E., Verlinden L. et al. Altered expression of key players in vitamin D metabolism and signaling in malignant and benign thyroid tumors. J Histochem Cytochem: 2012; 60.7 502 511
17. Clinckspoor I., Verlinden L., Mathieu C. et al. Vitamin D in thyroid tumorigenesis and development. Prog Histochem Cytochem: 2013; 48.2 65 98
18. Clinckspoor I., Verlinden L., Overbergh L. et al. 1,25-dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer. J Steroid Biochem Mol Biol: 2011; 124.1-2 1 9
19. D'Aurizio F., Villalta D., Metus P. et al. Is vitamin D a player or not in the pathophysiology of autoimmune thyroid diseases? Autoimmun Rev: 2014
20. Demir K., Keskin M., Kor Y. et al. Autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus is associated with elevated IgG4 but not with low vitamin D. Hormones (Athens): 2014; 13.3 361 368
21. Effraimidis G., Badenhoop K., Tijssen J. G. et al. Vitamin D deficiency is not associated with early stages of thyroid autoimmunity. Eur J Endocrinol: 2012; 167.1 43 48
22. Effraimidis G., Wiersinga W. M. Mechanisms in endocrinology: autoimmune thyroid disease: old and new players. Eur J Endocrinol: 2014; 170.6 R241 R252
23. Feng M., Li H., Chen S. F. et al. Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine: 2013; 43.2 318 326
24. Fournier C., Gepner P., Sadouk M. et al. In vivo beneficial effects of cyclosporin A and 1,25-dihydroxyvitamin D3 on the induction of experimental autoimmune thyroiditis. Clin Immunol Immunopathol: 1990; 54.1 53 63
25. Goswami R., Marwaha R. K., Gupta N. et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr: 2009; 102.3 382 386
26. Grant W. B. Ecological studies of the UVB-vitamin D-cancer hypothesis. Anticancer Res: 2012; 32.1 223 236
27. Grant W. B. Hypothesis - ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem Photobiol: 2008; 84.2 356 365
28. Holick M. F. Vitamin D deficiency. N Engl J Med: 2007; 357.3 266 281
29. Inoue N., Watanabe M., Ishido N. et al. The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases. Clin Exp Immunol: 2014; 178.2 262 269
30. Jastrup B., Mosekilde L., Melsen F. et al. Serum levels of vitamin D metabolites and bone remodelling in hyperthyroidism. Metabolism: 1982; 31.2 126 132
31. Jones G. Extrarenal vitamin D activation and interactions between vitamin D(2), vitamin D(3), and vitamin D analogs. Annu Rev Nutr: 2013; 33 23 44
32. Jonklaas J., Danielsen M., Wang H. A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid: 2013; 23.9 1079 1086
33. Kawakami-Tani T., Fukawa E., Tanaka H. et al. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease. Metabolism: 1997; 46.10 1184 1188
34. Khadzkou K., Buchwald P., Westin G. et al. 25-hydroxyvitamin D3 1alpha-hydroxylase and vitamin D receptor expression in papillary thyroid carcinoma. J Histochem Cytochem: 2006; 54.3 355 361
35. Kim J. R., Kim B. H., Kim S. M. et al. Low serum 25 hydroxyvitamin d is associated with poor clinicopathologic characteristics in female patients with papillary thyroid cancer. Thyroid: 2014; 24.11 1618 1624
36. Kivity S., Agmon-Levin N., Zisappl M. et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol: 2011; 8.3 243 247
37. Krysiak R., Kowalska B., Okopien B. Serum 25-Hydroxyvitamin D and parathyroid hormone levels in non-lactating women with postpartum thyroiditis: The effect of L-Thyroxine treatment. Basic Clin Pharmacol Toxicol: 2014
38. Kurylowicz A., Badenhoop K. CYP27B1 gene polymorphism is associated with Graves' disease in a Polish population study. Thyroid: 2005; 15.9 1107 1108
39. Kurylowicz A., Ramos-Lopez E., Bednarczuk T. et al. Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study. Exp Clin Endocrinol Diabetes: 2006; 114.6 329 335
40. Laney N., Meza J., Lyden E. et al. The Prevalence of Vitamin D Deficiency Is Similar between Thyroid Nodule and Thyroid Cancer Patients. Int J Endocrinol: 2010; 2010 805716
41. Lin W. Y., Wan L., Tsai C. H. et al. Vitamin D receptor gene polymorphisms are associated with risk of Hashimoto's thyroiditis in Chinese patients in Taiwan. J Clin Lab Anal: 2006; 20.3 109 112
42. Liu S., Xiong F., Liu E. M. et al. Effects of 1,25-dihydroxyvitamin D3 in rats with experimental autoimmune thyroiditis. Nan Fang Yi Ke Da Xue Xue Bao: 2010; 30.7 1573 1576
43. Liu W., Asa S. L., Fantus I. G. et al. Vitamin D Arrests Thyroid Carcinoma Cell Growth and Induces p27 Dephosphorylation and Accumulation through PTEN/Akt-Dependent and -Independent Pathways. Am J Pathol: 2002; 160.2 511 519
44. Lizis-Kolus K., Hubalewska-Dydejczyk A., Trofimiuk-Muldnerz M. et al. Assessment of 25(OH)D3, concentration levels in patients with papillary thyroid cancer compared to patients with Hashimoto's thyroiditis. Przegl Lek: 2013; 70.11 920 925
45. Lopez E. R., Zwermann O., Segni M. et al. A promoter polymorphism of the CYP27B1 gene is associated with Addison's disease, Hashimoto's thyroiditis, Graves' disease and type 1 diabetes mellitus in Germans. Eur J Endocrinol: 2004; 151.2 193 197
46. MacFarlane I. A., Mawer E. B., Berry J. et al. Vitamin D metabolism in hyperthyroidism. Clin Endocrinol (Oxf): 1982; 17.1 51 59
47. Mackawy A. M., Al-Ayed B. M., Al-Rashidi B. M. Vitamin d deficiency and its association with thyroid disease. Int J Health Sci (Qassim): 2013; 7.3 267 275
48. Mansournia N., Mansournia M. A., Saeedi S. et al. The association between serum 25OHD levels and hypothyroid Hashimoto's thyroiditis. J Endocrinol Invest: 2014; 37.5 473 476
49. Morand G. B., da Silva S. D., Hier M. P. et al. Insights into Genetic and Epigenetic Determinants with Impact on Vitamin D Signaling and Cancer Association Studies: The Case of Thyroid Cancer. Front Oncol: 2014; 4 309
50. Muscogiuri G., Mitri J., Mathieu C. et al. Mechanisms in endocrinology: vitamin D as a potential contributor in endocrine health and disease. Eur J Endocrinol: 2014; 171.3 R101 R110
51. Pani M. A., Regulla K., Segni M. et al. A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis. The Journal Of Clinical Endocrinology And Metabolism: 2002; 87.6 2564 2567
52. Pani M. A., Regulla K., Segni M. et al. Vitamin D 1alpha-hydroxylase (CYP1alpha) polymorphism in Graves' disease, Hashimoto's thyroiditis and type 1 diabetes mellitus. European Journal Of Endocrinology/European Federation Of Endocrine Societies: 2002; 146.6 777 781
53. Penna-Martinez M., Ramos-Lopez E., Stern J. et al. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid: 2009; 19.6 623 628
54. Penna-Martinez M., Ramos-Lopez E., Stern J. et al. Impaired vitamin D activation and association with CYP24A1 haplotypes in differentiated thyroid carcinoma. Thyroid: 2012; 22.7 709 716
55. Pludowski P., Holick M. F., Pilz S. et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality - a review of recent evidence. Autoimmun Rev: 2013; 12.10 976 989
56. Prietl B., Treiber G., Pieber T. R. et al. Vitamin D and immune function. Nutrients: 2013; 5.7 2502 2521
57. Roskies M., Dolev Y., Caglar D. et al. Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J. Otolaryngol Head Neck Surg: 2012; 41.3 160 163
58. Ross D. S. Thyroid hormone synthesis and physiology. UpToDate. 2015; Web
59. Rotondi M., Chiovato L. Vitamin D deficiency in patients with Graves' disease: probably something more than a casual association. Endocrine: 2013; 43.1 3 5
60. Sahin M., Ucan B., Ginis Z. et al. Vitamin D3 levels and insulin resistance in papillary thyroid cancer patients. Med Oncol: 2013; 30.2 589
61. Schottker B., Haug U., Schomburg L. et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr: 2013; 97.4 782 793
62. Sharma V., Fretwell D., Crees Z. et al. Thyroid cancer resistance to vitamin D receptor activation is associated with 24-hydroxylase levels but not the ff FokI polymorphism. Thyroid: 2010; 20.10 1103 1111
63. Shin D. Y., Kim K. J., Kim D. et al. Low serum vitamin D is associated with anti-thyroid peroxidase antibody in autoimmune thyroiditis. Yonsei Med J: 2014; 55.2 476 481
64. Speeckaert M., Huang G., Delanghe J. R. et al. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta: 2006; 372.1-2 33 42
65. Stefanic M., Karner I., Glavas-Obrovac L. et al. Association of vitamin D receptor gene polymorphism with susceptibility to Graves' disease in Eastern Croatian population: case-control study. Croat Med J: 2005; 46.4 639 646
66. Stepien T., Krupinski R., Sopinski J. et al. Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer. Arch Med Res: 2010; 41.3 190 194
67. Stocklin E., Eggersdorfer M. Vitamin D, an essential nutrient with versatile functions in nearly all organs. Int J Vitam Nutr Res: 2013; 83.2 92 100
68. Szczeklik A., Augustynowicz-Kopeć E. Choroby wewnetrzne: stan wiedzy na rok 2011. Kraków Medycyna Praktyczna: 2011; 2011
69. Theodoratou E., Tzoulaki I., Zgaga L. et al. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ: 2014; 348 g2035
70. Unal A. D., Tarcin O., Demirag N. G. et al. Vitamin D deficiency is related to thyroid antibodies in autoimmune thyroiditis. Central European Journal of Immunology: 2014; 39.4 493 497
71. Wacker M., Holick M. F. Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol: 2013; 5.1 51 108
72. Xu Y., He B., Pan Y. et al. Systematic review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Tumour Biol: 2014; 35.5 4153 4169
73. Yasuda T., Okamoto Y., Hamada N. et al. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease. Endocrine: 2012; 42.3 739 741
74. Yasuda T., Okamoto Y., Hamada N. et al. Serum vitamin D levels are decreased in patients without remission of Graves' disease. Endocrine: 2013; 43.1 230 232
75. Yazici D., Yavuz D., Tarcin O. et al. Vitamin D receptor gene ApaI, TaqI, FokI and BsmI polymorphisms in a group of Turkish patients with Hashimoto's thyroiditis. Minerva Endocrinol: 2013; 38.2 195 201
76. Yin K., Agrawal D. K. Vitamin D and inflammatory diseases. Journal Of Inflammation Research: 2014; 7 69 87
77. Zhang H., Liang L., Xie Z. Low vitamin D status is associated with increased titers of thyroid stimulating hormone receptor antibodies in Graves' disease. Endocr Pract: 2014; 1 23
78. Zhang L. R., Sawka A. M., Adams L. et al. Vitamin and mineral supplements and thyroid cancer: a systematic review. Eur J Cancer Prev: 2013; 22.2 158 168
79. Zhang Q., Wang Z., Sun M. et al. Association of high vitamin D status with low circulating thyroid-stimulating hormone independent of thyroid hormone levels in middle-aged and elderly males. Int J Endocrinol: 2014; Epub 2014 Feb
80. Zhou H., Xu C., Gu M. Vitamin D receptor (VDR) gene polymorphisms and Graves' disease: a meta-analysis. Clin Endocrinol (Oxf): 2009; 70.6 938 945
81. Zou M., BinHumaid F. S., Alzahrani A. S. et al. Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma. Clin Endocrinol (Oxf): 2014; 81.1 109 116